Paper6804591
In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.
Krolick KA and 3 others. J Exp Med, 1982. Cited by 130 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. Papers, record 6804591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6804591
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitoxins | Major topic |
| B-Lymphocytes | Major topic |
| Lectins | Major topic |
| Leukemia, Experimental | Major topic |
| Plant Lectins | Major topic |
| Plant Proteins | Major topic |
| Animals | |
| Antibodies, Anti-Idiotypic | |
| Cell Transformation, Neoplastic | |
| Fluorescent Antibody Technique | |
| Immunoglobulin delta-Chains | |
| Leukocyte Count | |
| Lymphoid Tissue | |
| Mice | |
| Mice, Inbred BALB C | |
| Rabbits | |
| Splenectomy |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI-15387 | NIAID NIH HHS | United States | R01AI015387 | PubMed and NIH | NIH RePORTER |
| CA-28149 | NCI NIH HHS | United States | R01CA028149 | PubMed and NIH | NIH RePORTER |
| CA-30313 | NCI NIH HHS | United States | R01CA030313 | PubMed and NIH | NIH RePORTER |
| R37CA028149 | NIH | NIH RePORTER |
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,343,471 | Antitumor effects of antibody-diphtheria toxin conjugates: use of hapten-coated tumor cells as an antigenic target. | J Natl Cancer Inst | 1972 | https://conductscience.org/library/papers/4343471 | PubMed |
| 2 | 1,090,697 | Cell surface immunoglobulin. XI. The appearance of an IgD-like molecule on murine lymphoid cells during ontogeny. | J Exp Med | 1975 | https://conductscience.org/library/papers/1090697 | PubMed |
| 3 | 169,378 | Antitumor effects of antibody-diphtheria toxin conjugates. II. Immunotherapy with conjugates directed against tumor antigens induced by simian virus 40. | J Natl Cancer Inst | 1975 | https://conductscience.org/library/papers/169378 | PubMed |
| 4 | 1,082,551 | Preparation and characterisation of an antiserum to the mouse candidate for immunoglobulin D. | Nature | 1976 | https://conductscience.org/library/papers/1082551 | PubMed |
| 5 | 323,402 | The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. I. Surface immunoglobulin isotypes on primed B cells in the spleen. | J Exp Med | 1977 | https://conductscience.org/library/papers/323402 | PubMed |
| 6 | 17,647 | Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. | J Exp Med | 1977 | https://conductscience.org/library/papers/17647 | PubMed |
| 7 | 894,051 | Cell surface immunoglobulin. XXII. Reappearance of surface IgM and IgD on murine splenocytes after removal by capping. | J Immunol | 1977 | https://conductscience.org/library/papers/894051 | PubMed |
| 8 | 306,069 | Spontaneous murine B-cell leukaemia. | Nature | 1978 | https://conductscience.org/library/papers/306069 | PubMed |
| 9 | 97,669 | Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/97669 | PubMed |
| 10 | 567,555 | Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. | Curr Top Microbiol Immunol | 1978 | https://conductscience.org/library/papers/567555 | PubMed |
| 11 | 80,453 | Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects. | J Natl Cancer Inst | 1978 | https://conductscience.org/library/papers/80453 | PubMed |
| 12 | 109,513 | Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody. | J Immunol | 1979 | https://conductscience.org/library/papers/109513 | PubMed |
| 13 | 313,960 | Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR. | J Immunol | 1979 | https://conductscience.org/library/papers/313960 | PubMed |
| 14 | 39,027 | Allograft tolerance after total lymphoid irradiation (TLI). | Immunol Rev | 1979 | https://conductscience.org/library/papers/39027 | PubMed |
| 15 | 385,772 | Murine B cell leukemia (BCL1): organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody. | J Immunol | 1979 | https://conductscience.org/library/papers/385772 | PubMed |
| 16 | 496,982 | Preparation of a hybrid of fragment Fab' of antibody and fragment A of diphtheria toxin and its cytotoxicity. | Biochem Biophys Res Commun | 1979 | https://conductscience.org/library/papers/496982 | PubMed |
| 17 | 6,965,909 | Increased toxicity of diphtheria toxin for human lymphoblastoid cells following covalent linkage to anti-(human lymphocyte) globulin or its F(ab')2 fragment. | Eur J Biochem | 1980 | https://conductscience.org/library/papers/6965909 | PubMed |
| 18 | 121,100 | Immunobiology of a spontaneous murine B cell leukemia (BCL1). | Immunol Rev | 1979 | https://conductscience.org/library/papers/121100 | PubMed |
| 19 | 94,899 | BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor. | Immunol Rev | 1979 | https://conductscience.org/library/papers/94899 | PubMed |
| 20 | 398,327 | Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. | Immunol Rev | 1979 | https://conductscience.org/library/papers/398327 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,181,593 | Clinically approved immunotoxins targeting hematological cancers: "the best of both worlds". | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41181593 | PubMed |
| 9,227,858 | Yeast killer systems. | Clin Microbiol Rev | 1997 | https://conductscience.org/library/papers/9227858 | PubMed |
| 8,481,059 | IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases. | Ann Rheum Dis | 1993 | https://conductscience.org/library/papers/8481059 | PubMed |
| 7,811,557 | Radioimmunodetection of cancer of gastrointestinal tract and liver metastasis with I-131 anti-CEA and I-131 anti-CA19-9 monoclonal antibody cocktail (IMACIS-1). | Ann Nucl Med | 1994 | https://conductscience.org/library/papers/7811557 | PubMed |
| 7,513,431 | Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7513431 | PubMed |
| 6,577,942 | Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6577942 | PubMed |
| 6,351,310 | Treatment of lymphoid tumors with anti-idiotype antibodies. | Springer Semin Immunopathol | 1983 | https://conductscience.org/library/papers/6351310 | PubMed |
| 3,543,527 | Immunotoxin therapy of malignant melanoma. | Med Oncol Tumor Pharmacother | 1986 | https://conductscience.org/library/papers/3543527 | PubMed |
| 3,494,997 | Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins: nude mouse models. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3494997 | PubMed |
| 3,110,351 | Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin. | J Exp Med | 1987 | https://conductscience.org/library/papers/3110351 | PubMed |
| 2,997,783 | Targeting of loaded Sendai virus envelopes by covalently attached insulin molecules to virus receptor-depleted cells: fusion-mediated microinjection of ricin A and simian virus 40 DNA. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/2997783 | PubMed |
| 2,993,314 | Selective destruction of nerve growth factor receptor-bearing cells in vitro using a hybrid toxin composed of ricin A chain and a monoclonal antibody against the nerve growth factor receptor. | J Cell Biol | 1985 | https://conductscience.org/library/papers/2993314 | PubMed |
| 2,081,785 | Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS. | J Clin Immunol | 1990 | https://conductscience.org/library/papers/2081785 | PubMed |
| 1,731,346 | Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1731346 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6804591
GET https://conductscience.org/api/papers/v1/6804591/references?page=2